Class Action Lawsuit Filed Against Dow Inc. by Pomerantz Law Firm

Pomerantz Law Firm Class Action Against Dow Inc.

On October 13, 2025, Pomerantz LLP announced the filing of a class action lawsuit against Dow Inc. and certain of its officers. This action, documented in the United States District Court for the Eastern District of Michigan under case number 25-cv-12744, pertains to all individuals and entities who purchased or acquired Dow securities between January 30, 2025, and July 23, 2025. The core issue centers around the alleged violations of federal securities laws, specifically under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5.

Background of the Case

The lawsuit seeks to recover damages for investors impacted during the defined Class Period. Individuals who invested in Dow securities during this timeframe are encouraged to consider applying for lead plaintiff status in this case before the October 28, 2025, deadline. For detailed information about the complaint or the class action process, potential plaintiffs can visit www.pomerantzlaw.com or contact Danielle Peyton at (646) 581-9980.

Dow Inc. is recognized as a global leader in materials science, serving diverse markets such as packaging, infrastructure, and consumer applications. The company's operations are divided into six global business units, which fall into three segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.

For investors, Dow has long emphasized the importance of its dividend in its investment thesis, with CEO Jim Fitterling asserting that the dividend is a key reason many stockholders remain invested. Despite a struggling materials science environment and uncertainty due to tariffs, Dow's leadership insisted the company was well-equipped to navigate these challenges.

The Misrepresentation Allegations

During the class period, Dow's top executives allegedly misrepresented the company's financial health and operational resilience. They asserted that Dow could withstand economic pressures and tariff fluctuations while maintaining a viable dividend. This claim, according to the lawsuit, overstated the company’s abilities to address competitive pricing challenges and the broader impacts of diminishing global demand for its products.

Reports from BMO Capital on June 23, 2025, indicated a reduced recommendation for Dow's stock from